D-0946-2023 Class II
FDA drug recall D-0946-2023 was initiated by The Ritedose Corporation on Jul 21, 2023 and is designated Class II. Reason for recall: CGMP deviation: product released prior to supplier approval. Affected quantity: 44 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 9, 2023
- Initiation Date
- Jul 21, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 44 cartons
Product description
Cromolyn Sodium Oral Solution (Concentrate) 100 mg/5 mL 96 Plastic Ampules per carton, Rx Only, For Oral Use Only - Not For Inhalation or Injection, Must be Diluted, Manufactured by: The Ritedose Corporation Columbia, SC 29203 for Ritedose Pharmaceuticals, LLC Columbia, SC 29203, NDC 76204-025-96.
Reason for recall
CGMP deviation: product released prior to supplier approval.
Distribution pattern
Nationwide in the US
Code information
Lot: 23CE2, Exp. 03/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0946-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026